CD47 and neoplasm: CD47 binds to a myeloid and neuronal cell receptor called signal regulatory protein α (SIRPα), which initiates a signaling cascade within the bound phagocyte via immunoreceptor tyrosine-based inhibition motifs to inhibit immunoglobulin- or complement-induced efferocytosis of the tumor cell[3,4].